Zobrazeno 1 - 10
of 24
pro vyhledávání: '"TAKUYA KUMAZAWA"'
Autor:
Kohei Okada, MD, Hiro Sato, MD, PhD, Takuya Kumazawa, MD, PhD, Yasumasa Mori, MD, PhD, Tiara Bunga Mayang Permata, MD, PhD, Yuki Uchihara, PhD, Shin-ei Noda, MD, PhD, Keiji Suzuki, PhD, Hayato Ikota, MD, PhD, Hideaki Yokoo, MD, PhD, Soehartati Gondhowiardjo, MD, PhD, Takashi Nakano, MD, PhD, Tatsuya Ohno, MD, PhD, Atsushi Shibata, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 3, Pp 101159- (2023)
Purpose: Understanding the immune response during radiation therapy (RT) in a clinical setting is imperative for maximizing the efficacy of combined RT and immunotherapy. Calreticulin, a major damage-associated molecular pattern that is exposed on th
Externí odkaz:
https://doaj.org/article/1c71cdb0efb04fe4971ceca77d21770d
Autor:
Kazuho Nishimura, Takuya Kumazawa, Takao Kuroda, Naohiro Katagiri, Mai Tsuchiya, Natsuka Goto, Ryohei Furumai, Akiko Murayama, Junn Yanagisawa, Keiji Kimura
Publikováno v:
Cell Reports, Vol 10, Iss 8, Pp 1310-1323 (2015)
The 5S ribonucleoprotein particle (RNP) complex, consisting of RPL11, RPL5, and 5S rRNA, is implicated in p53 regulation under ribotoxic stress. Here, we show that the 5S RNP contributes to p53 activation and promotes cellular senescence in response
Externí odkaz:
https://doaj.org/article/069e6be3279643a59b0f5e89ca0da1da
Autor:
Takashi Nakano, Shin-ei Noda, Sangeeta Kakoti, Tiara Bunga Mayang Permata, Soehartati Gondhowiardjo, Keiji Suzuki, Atsushi Shibata, Hideaki Yokoo, Takuya Kumazawa, Tatsuya Ohno, Yasumasa Mori, Yuki Uchihara, Hayato Ikota, Kohei Okada, Hiro Sato
Publikováno v:
Oncology Letters
The growing importance of antitumour immunity by cancer immunotherapy has prompted studies on radiotherapy-induced immune response. Previous studies have indicated that programmed cell death-1 ligand (PD-L1) expression is regulated by DNA damage sign
Publikováno v:
In Vivo
Background/Aim: Stereotactic radiotherapy (SRT) for spine metastases with helical tomotherapy requires a long irradiation time due to the high dose per fraction. Since helical tomotherapy can neither confirm nor correct the position during irradiatio
Autor:
Yuhei Miyasaka, Takashi Nakano, Kazuaki Chikamatsu, Hidemasa Kawamura, Shohei Okazaki, Takuya Kumazawa, Katsuyuki Shirai, Atsushi Musha, Nobuteru Kubo, Takahiro Oike, Makoto Sakai, Tatsuya Ohno, Daijiro Kobayashi, Yoshiki Kubota, Jun ichi Saitoh, Tatsuji Mizukami, Satoshi Yokoo, Hiro Sato
Publikováno v:
Radiotherapy and Oncology. 141:72-77
Little information is available on the risk factors for nasolacrimal duct obstruction after radiotherapy for head and neck tumors. We investigated the incidence and predictive dosimetric parameters for nasolacrimal duct obstruction following carbon-i
Autor:
Yasuki Nakada, Ayako Seno, Satomi Ishihara, Naoto Minamino, Tomoya Ueda, Takuya Kumazawa, Makoto Watanabe, Rika Kawakami, Tsunenari Soeda, Yoshihiko Saito, Satoshi Okayama, Nobuhisa Iwata, Kenji Onoue, Taku Nishida, Hiroshi Hosoda, Tomoya Nakano, Hitoshi Nakagawa
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 77(6)
NEP (Neprilysin) degrades natriuretic peptides, and its inhibition is a clinically accepted target for heart failure treatment. NEP is widely expressed in various organs, including the heart. However, the pathophysiological significance of local card
Autor:
Keiji Suzuki, Yuya Yoshimoto, Hayato Ikota, Kazutoshi Murata, Noriyuki Okonogi, Takashi Nakano, Atsushi Shibata, Takuya Kaminuma, Yasumasa Mori, Ken Ando, Hiro Sato, Shin-ei Noda, Kohei Okada, Tiara Bunga Mayang Permata, Takahiro Oike, Takuya Kumazawa, Hideaki Yokoo, Sangeeta Kakoti, Tatsuya Ohno
Publikováno v:
Oncol Lett
Radiotherapy induces an immune response in the cancer microenvironment that may influence clinical outcome. The present study aimed to analyse the alteration of CD8(+) T-cell infiltration and programmed death-ligand 1 (PD-L1) expression following rad
Autor:
Daisuke Irie, Kento Tomizawa, Takuya Kumazawa, Takahiro Oike, Tatsuya Ohno, Takuya Kaminuma, Kazutoshi Murata
Publikováno v:
Poster.
Introduction Three-dimensional image-guided brachytherapy (3D-IGBT) has become widespread, improving the outcomes of cervical cancers dramatically. In 2018, the International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical
Autor:
Shin-ei Noda, Daisuke Irie, Takuya Kumazawa, Takuya Kaminuma, Kento Tomizawa, Takahiro Oike, Tatsuya Ohno, Kazutoshi Murata
Publikováno v:
Cancers, Vol 12, Iss 1770, p 1770 (2020)
Cancers
Volume 12
Issue 7
Cancers
Volume 12
Issue 7
Recent widespread use of three-dimensional image-guided brachytherapy (3D-IGBT) has improved radiotherapy outcomes of cervical cancer dramatically. In 2018, the International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical
Publikováno v:
In Vivo; Jan/Feb2022, Vol. 36 Issue 1, p330-335, 6p